Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 57

Sort by

Sort Order Select

Journal Articles

Low incidence of agvhd with ptcy, tacrolimus and post-engraftment low dose ATG-based GvHD prophylaxis in haplo-identical donor transplantation and establish of new predict score for grade II-iv agvhd

Lining Wang, Wenhui Gao, Jieling Jiang, ling Wang, Jiong Hu

Blood (2025) 146 (Supplement 1): 4224.

https://doi.org/10.1182/blood-2025-4224

Published: 2025

Journal Articles

A predictive model for treatment failure in CLL/SLL patients receiving BTK inhibitor: A multi-center retrospective study

Yutang Li, Xinting Hu, Yupiao Feng, Ling Wang, Xiaoqian Liu, Xiangxiang Zhou

Blood (2025) 146 (Supplement 1): 7423.

https://doi.org/10.1182/blood-2025-7423

Published: 2025

Journal Articles

Total marrow irradiation based conditioning for allogeneic hematopoietic stem cell transplantation in elderly or frail patients with hematological malignancies: A single center analysis

Jieling Jiang, Jiong Hu, ling Wang, Wenhui Gao, Lining Wang

Blood (2025) 146 (Supplement 1): 2444.

https://doi.org/10.1182/blood-2025-2444

Published: 2025

Journal Articles

Longitudinal immune reconstitution dynamics in refractory T-ALL treated with CD7 CAR-T cells bridging to allogeneic stem cell transplantation

Guo-Ling Wang, Han-Peng Luo, Ting Wang, Hai-Chan Xu, Li-Hua Sun, Bao-Zhen Qin, Hongyu Zhang, Jia Feng, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 3325.

https://doi.org/10.1182/blood-2025-3325

Published: 2025

Journal Articles

The impact of HLA loss of heterozygosity on outcome after haploidentical hematopoietic stem cell transplantation in hematological malignancies

Xingyu Cao, Jian-ling Wang, Yanli Zhao, Min Xiong, Yue Lu, Ruijuan Sun, Jian-Ping Zhang, Deyan Liu, Jiarui Zhou, Zhijie Wei, Peihua Lu

Blood (2025) 146 (Supplement 1): 2498.

https://doi.org/10.1182/blood-2025-2498

Published: 2025

Journal Articles

Discrimination of Epstein–Barr virus latent infection and lytic replication reactivation using a novel methyl-CRISPR biosensor

Ting Wang, Guo-Ling Wang, Jingli Han, Lixin Wu, Yuanyuan Zhang, Hai-Xia Fu, Jia Feng, Hongyu Zhang, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 394.

https://doi.org/10.1182/blood-2025-394

Published: 2025

Journal Articles

Low CMV and EBV infections in the era of letermovir with post-transplantation cyclophosphamide combined with tacrolimus and low-dose post engraftment ATG as gvhd prophylaxis.

Wenhui Gao, Lining Wang, ling Wang, Jieling Jiang, Jiong Hu

Blood (2025) 146 (Supplement 1): 4271.

https://doi.org/10.1182/blood-2025-4271

Published: 2025

Journal Articles

Efficacy and safety of luspatercept in the treatment of anemia in allo-HSCT for patients with hematological diseases

Shi-wei Jin, Mengmeng Pan, Weiping Zhang, Jiong Hu, Jian-Qing Mi, ling Wang

Blood (2025) 146 (Supplement 1): 2438.

https://doi.org/10.1182/blood-2025-2438

Published: 2025

Journal Articles

Role and Mechanisms Exploration of Histamine and Its Receptors in the Progression of Peripheral T-Cell Lymphoma

Hui Jin, Ling Wang, Yimin Ren, Zijuan Wu, Wenyu Shi, Jianyong Li

Blood (2024) 144 (Supplement 1): 4378.

https://doi.org/10.1182/blood-2024-211896

Published: 2024

Journal Articles

Chidamide Maintenance Therapy for Patients with Peripheral T-Cell Lymphoma: A Multicenter Real-World Analysis

Wenjing Jiang, Xiyuan Zhang, Wei Song, Hong Xu, Changrong Wei, Juan Wang, Ling Wang

Blood (2024) 144 (Supplement 1): 6508.

https://doi.org/10.1182/blood-2024-200160

Published: 2024

Journal Articles

The G6PD a- Variant Does Not Modulate Pulmonary Hypertension Phenotypes in Mice

Mouna Ouchari, Qinzi Xu, Akueba Bruce, Ling Wang, Elizabeth Rochon, Mark T. Gladwin

Blood (2024) 144 (Supplement 1): 1081.

https://doi.org/10.1182/blood-2024-205417

Published: 2024

Journal Articles

Tandem CAR-T-Cell Therapy Targeting CD5 and CD7: Facilitating Condition-Free Engraftment of Epitope-Edited Allogeneic HSCs

Guo-Ling Wang, Ting Wang, Jing-Li Han, Li-Xin Wu, Xuan-Zhong Chen, Zhuo-Yu An, Chen-Cong Wang, Peng Zhao, Lu-Lu Wang, Meng-Tong Zang, Wei Zheng, Hai-Xia Fu, Jia Feng, Hong-Yu Zhang, Xiaohui Zhang

Blood (2024) 144 (Supplement 1): 2041.

https://doi.org/10.1182/blood-2024-208043

Published: 2024

Journal Articles

A Pro-Inflammatory Gene Signature Characterizes a Better Risk Aged AML Patient Group in ECOG-ACRIN Cancer Research Group's Clinical Trial E3999

Blood (2023) 142 (Supplement 1): 4326.

https://doi.org/10.1182/blood-2023-179569

Published: 2023

Journal Articles

Efficacy and Safety Analysis of Carfilzomib-Containing Regimen in the Treatment of Multiple Myeloma：a Multicenter Real-World Study

Na Liu, Luqun WANG, Rentong Liu, Yuping Zhong, Xianqi Feng, Zhongliang Sun, Jie Li, Fanjun Meng, Junjie MA, Changyong Yuan, Hao Li, Ling Wang, Zhilong Xu, Jie Yu, Hao Zhang, Chen Chunyan

Blood (2023) 142 (Supplement 1): 6632.

https://doi.org/10.1182/blood-2023-179687

Published: 2023

Journal Articles

Sec14l4 SNP Mice Have Increased Susceptibility to Oxidative Hemolysis through Modulation of G6PD and the Pentose Phosphate Pathway

Nuzhat Kabir, Angelo D'Alessandro, Ling Wang, Mark T. Gladwin, Elizabeth R Rochon

Blood (2022) 140 (Supplement 1): 5704–5705.

https://doi.org/10.1182/blood-2022-169183

Published: 2022

Journal Articles

SC-gtCAR19, a Non-Viral Genome Targeting Anti-CD19 CAR-T Candidate in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia: Updated Results from Long-Term Follow-up

Hui Wang, Ying Gao, Ding Zhang, Yan Zheng, Xingxing Hu, Qiuying Gao, Ben Niu, Limin Hou, Ling Wang, Weihua Zhang, Yi Zhang, Xingli Ru, Le Li, Zuohan Peng, Yi Wang

Blood (2022) 140 (Supplement 1): 4623–4624.

https://doi.org/10.1182/blood-2022-159871

Published: 2022

Journal Articles

Post-Transplantation Cyclophosphamide Combined with Tacrolimus and Low-Dose Post-Engraftment Anti-Thymoglobulin As Gvhd Prophylaxis for Patients Undergoing Peripheral Blood Stem Cell Transplantation from Haplo Donors: A Single Center Analysis

Jiong Hu, Wenhui GAO, Ming Chen, Li-Ling Wang, Ling Wang, Raynier Devillier, Jie-Ling Jiang, Didier Blaise

Blood (2022) 140 (Supplement 1): 12878–12879.

https://doi.org/10.1182/blood-2022-168484

Published: 2022

Journal Articles

Oligosecretory Waldenström Macroglobulinemia Patients Exhibit Excellent Treatment Response and Outcomes

Blood (2022) 140 (Supplement 1): 9289–9291.

https://doi.org/10.1182/blood-2022-157311

Published: 2022

Journal Articles

Targeting HDAC3 to Overcome the Resistance to ATRA or Arsenic in Acute Promyelocytic Leukemia through Ubiquitination and Degradation of PML-RARα

Bo Dai, Feng Wang, Ying Wang, Jiayan Zhu, Yunxuan Li, Tingting Zhang, Luyao Zhao, Li-Ling Wang, Wenhui GAO, Junmin Li, Aibin Liang, Hong-hu Zhu, Ke Li, Jiong Hu

Blood (2022) 140 (Supplement 1): 5924–5925.

https://doi.org/10.1182/blood-2022-156735

Published: 2022

Journal Articles

CD123 Directed IgM Antibody-based T-cell Engager, IGM-2537, Demonstrates Potent in vitro and in vivo Activity with Minimal Cytokine Release

Liqin Liu, Gene Li, Ling Wang, Poonam Yakkundi, Paul R. Hinton, Deepal Pandya, Manal Amoury, Keerthana Sekar, Chian Liu, Rodnie Rosete, Nardeen Hanna, Maya F. Kotturi, Liz Bogaert, Jiyoung Hong, Christina Tsai, Bruce A. Keyt, Angus M. Sinclair

Blood (2022) 140 (Supplement 1): 5918–5919.

https://doi.org/10.1182/blood-2022-165817

Published: 2022

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Low incidence of agvhd with ptcy, tacrolimus and post-engraftment low dose ATG-based GvHD prophylaxis in haplo-identical donor transplantation and establish of new predict score for grade II-iv agvhd

A predictive model for treatment failure in CLL/SLL patients receiving BTK inhibitor: A multi-center retrospective study

Total marrow irradiation based conditioning for allogeneic hematopoietic stem cell transplantation in elderly or frail patients with hematological malignancies: A single center analysis

Longitudinal immune reconstitution dynamics in refractory T-ALL treated with CD7 CAR-T cells bridging to allogeneic stem cell transplantation

The impact of HLA loss of heterozygosity on outcome after haploidentical hematopoietic stem cell transplantation in hematological malignancies

Discrimination of Epstein–Barr virus latent infection and lytic replication reactivation using a novel methyl-CRISPR biosensor

Low CMV and EBV infections in the era of letermovir with post-transplantation cyclophosphamide combined with tacrolimus and low-dose post engraftment ATG as gvhd prophylaxis.

Efficacy and safety of luspatercept in the treatment of anemia in allo-HSCT for patients with hematological diseases

Role and Mechanisms Exploration of Histamine and Its Receptors in the Progression of Peripheral T-Cell Lymphoma

Chidamide Maintenance Therapy for Patients with Peripheral T-Cell Lymphoma: A Multicenter Real-World Analysis

The G6PD a- Variant Does Not Modulate Pulmonary Hypertension Phenotypes in Mice

Tandem CAR-T-Cell Therapy Targeting CD5 and CD7: Facilitating Condition-Free Engraftment of Epitope-Edited Allogeneic HSCs

A Pro-Inflammatory Gene Signature Characterizes a Better Risk Aged AML Patient Group in ECOG-ACRIN Cancer Research Group's Clinical Trial E3999

Efficacy and Safety Analysis of Carfilzomib-Containing Regimen in the Treatment of Multiple Myeloma：a Multicenter Real-World Study

Sec14l4 SNP Mice Have Increased Susceptibility to Oxidative Hemolysis through Modulation of G6PD and the Pentose Phosphate Pathway

SC-gtCAR19, a Non-Viral Genome Targeting Anti-CD19 CAR-T Candidate in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia: Updated Results from Long-Term Follow-up

Post-Transplantation Cyclophosphamide Combined with Tacrolimus and Low-Dose Post-Engraftment Anti-Thymoglobulin As Gvhd Prophylaxis for Patients Undergoing Peripheral Blood Stem Cell Transplantation from Haplo Donors: A Single Center Analysis

Oligosecretory Waldenström Macroglobulinemia Patients Exhibit Excellent Treatment Response and Outcomes

Targeting HDAC3 to Overcome the Resistance to ATRA or Arsenic in Acute Promyelocytic Leukemia through Ubiquitination and Degradation of PML-RARα

CD123 Directed IgM Antibody-based T-cell Engager, IGM-2537, Demonstrates Potent in vitro and in vivo Activity with Minimal Cytokine Release

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only